Haykal, R., McGlotten, R., Bolan, C., Kalsi, S., & Nieman, L. K. (2020). MON-182 Increased Risk of Bleeding and Excessive Anticoagulation Using Standard Dose Low Molecular Weight Heparin (LMWH) in Cushing’s Syndrome. J Endocr Soc.
Citação norma ChicagoHaykal, Rasha, Raven McGlotten, Charles Bolan, Shelley Kalsi, and Lynnette K. Nieman. "MON-182 Increased Risk of Bleeding and Excessive Anticoagulation Using Standard Dose Low Molecular Weight Heparin (LMWH) in Cushing’s Syndrome." J Endocr Soc 2020.
Citação norma MLAHaykal, Rasha, et al. "MON-182 Increased Risk of Bleeding and Excessive Anticoagulation Using Standard Dose Low Molecular Weight Heparin (LMWH) in Cushing’s Syndrome." J Endocr Soc 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.